StonvexLoading…
StonvexStonvexStonvexCore line items from AGM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $415.96M | $1.61B | $1.20B | $780.44M |
Operating Income | $71.44M | $255.71M | $195.25M | $128.56M |
Net Income | $59.12M | $207.41M | $159.49M | $54.84M |
EPS (Diluted) | $4.75 | $16.62 | $12.93 | $8.49 |
Total Assets | $36.73B | $35.37B | $33.38B | $33.00B |
Total Liabilities | $35.01B | $33.65B | $31.69B | $31.45B |
Cash & Equivalents | $773.93M | $931.07M | $901.02M | $1.03B |
Free Cash Flow OCF − CapEx | Not available | $80.06M | $-23.35M | $-97.54M |
Shares Outstanding | 10.92M | 10.98M | 10.97M | 10.97M |